{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:06:52Z","timestamp":1784912812983,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01537-4","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:42:02Z","timestamp":1784911322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mortality Trends of Biliary Tract Cancers in the United States, 1999\u20132023: a CDC-WONDER Analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Jianguo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"1537_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.858639","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, Gui X, Zhang Y, et al. A panel of bile volatile organic compounds servers as a potential diagnostic biomarker for gallbladder cancer. Front Oncol. 2022;12:858639.","journal-title":"Front Oncol"},{"key":"1537_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01439","volume":"9","author":"H Feng","year":"2019","unstructured":"Feng H, Tong H, Yan J, et al. Genomic features and clinical characteristics of adolescents and young adults with cholangiocarcinoma. Front Oncol. 2019;9:1439.","journal-title":"Front Oncol"},{"issue":"1","key":"1537_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41575-025-01153-w","volume":"23","author":"JM Banales","year":"2026","unstructured":"Banales JM, Rodrigues PM, Aff\u00f2 S, et al. Cholangiocarcinoma 2026: status quo, unmet needs and priorities. Nat Rev Gastroenterol Hepatol. 2026;23(1):65\u201396.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1537_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12029-024-01132-5","volume":"56","author":"OU Rehman","year":"2025","unstructured":"Rehman OU, Hayat MS, Shoaib MM, et al. Trends and disparities in intrahepatic cholangiocarcinoma-related mortality in the United States from 1999 to 2020. J Gastrointest Cancer. 2025;56(1):53.","journal-title":"J Gastrointest Cancer"},{"issue":"5","key":"1537_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.124.011459","volume":"18","author":"AMK Minhas","year":"2025","unstructured":"Minhas AMK, Al-Kindi S, Van Spall HGC, et al. Comparing cardiovascular mortality estimates from Global Burden of Disease and from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research. Circ Cardiovasc Qual Outcomes. 2025;18(5):e011459.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"1537_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3945\/ajcn.116.131672","volume":"104","author":"DJ Hughes","year":"2016","unstructured":"Hughes DJ, Duarte-Salles T, Hybsier S, et al. Prediagnostic selenium status and hepatobiliary cancer risk in the European prospective investigation into cancer and nutrition cohort. Am J Clin Nutr. 2016;104(2):406\u201314.","journal-title":"Am J Clin Nutr"},{"key":"1537_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2026.116825","volume":"254","author":"A Alyahya","year":"2026","unstructured":"Alyahya A, Albegamy Y, Albalawi MA, et al. Trends in mortality from high-risk surgical procedures: national burden of Transplants, Implants, and Organ removal from 1999 to 2024 in United States. Am J Surg. 2026;254:116825.","journal-title":"Am J Surg"},{"issue":"11","key":"1537_CR8","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1097\/MS9.0000000000002629","volume":"86","author":"A Haseeb","year":"1999","unstructured":"Haseeb A, Muhammad Umer Nasrullah R, Siddiq MA, et al. Trends in malignant neoplasm of bone and articular cartilage related mortality among older adults in United States (1999\u20132020). Ann Med Surg. 1999;86(11):6645\u201352.","journal-title":"Ann Med Surg"},{"key":"1537_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/crd.0000000000001083","author":"M Ahmed","year":"1999","unstructured":"Ahmed M, Hasan M, Kumar S, et al. Trends and forecast of heart failure-related deaths in US chronic obstructive pulmonary disease patients (1999-2030): insights from advanced time-series modeling. Cardiol Rev. 1999. https:\/\/doi.org\/10.1097\/crd.0000000000001083.","journal-title":"Cardiol Rev"},{"issue":"10","key":"1537_CR10","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1007\/s11255-025-04490-6","volume":"57","author":"L Kumar","year":"2025","unstructured":"Kumar L, Ali T, Iqbal F, et al. Unveiling trends in urinary tract cancer mortality among older adults in the United States (1999\u20132022): a CDC WONDER perspective. Int Urol Nephrol. 2025;57(10):3151\u201361.","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"1537_CR11","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/cncr.31942","volume":"125","author":"AL Van Dyke","year":"1999","unstructured":"Van Dyke AL, Shiels MS, Jones GS, et al. Biliary tract cancer incidence and trends in the United States by demographic group, 1999\u20132013. Cancer. 1999;125(9):1489\u201398.","journal-title":"Cancer"},{"issue":"10","key":"1537_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186643","volume":"12","author":"JL Petrick","year":"2017","unstructured":"Petrick JL, Yang B, Altekruse SF, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based study in SEER-Medicare. PLoS ONE. 2017;12(10):e0186643.","journal-title":"PLoS ONE"},{"issue":"6","key":"1537_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/ijc.34308","volume":"152","author":"K Hemminki","year":"2023","unstructured":"Hemminki K, Sundquist K, Sundquist J, et al. Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers. Int J Cancer. 2023;152(6):1107\u201314.","journal-title":"Int J Cancer"},{"key":"1537_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1705162","volume":"15","author":"G Wu","year":"2025","unstructured":"Wu G, Xu X, Zhang H, et al. Liquid biopsy in biliary tract cancers: early diagnosis, precision therapy, and prognostic evaluation. Front Oncol. 2025;15:1705162.","journal-title":"Front Oncol"},{"key":"1537_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-025-04924-1","author":"L Kumar","year":"1999","unstructured":"Kumar L, Mustafa I, Kumar N, et al. Temporal trends in mortality attributable to atrial fibrillation among adults with acute renal failure in the United States, 1999-2024. Int Urol Nephrol. 1999. https:\/\/doi.org\/10.1007\/s11255-025-04924-1.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1537_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05036-5","volume":"25","author":"S Rani","year":"1999","unstructured":"Rani S, Kumar L, Ali SME, et al. Trends in United States mortality among patients with atrial fibrillation\/flutter related heart failure (1999-2024): disparities by gender, race\/ethnicity and region. BMC Cardiovasc Disord. 1999;25(1):558.","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"1537_CR17","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1097\/MS9.0000000000004729","volume":"88","author":"A Mahmood","year":"2026","unstructured":"Mahmood A, Latif F, Latif S, et al. Heart failure and tobacco use disorder: mortality trends and disparities in the United States. Ann Med Surg (Lond). 2026;88(2):1639\u201347.","journal-title":"Ann Med Surg (Lond)"},{"issue":"9","key":"1537_CR18","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1158\/1055-9965.EPI-21-0265","volume":"30","author":"TD Ellington","year":"2013","unstructured":"Ellington TD, Momin B, Wilson RJ, et al. Incidence and mortality of cancers of the biliary tract, gallbladder, and liver by sex, age, race\/ethnicity, and stage at diagnosis: United States, 2013 to 2017. Cancer Epidemiol Biomarkers Prev. 2013;30(9):1607\u201314.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1537_CR19","doi-asserted-by":"publisher","first-page":"1339312","DOI":"10.3389\/fneph.2023.1339312","volume":"3","author":"A Raja","year":"2023","unstructured":"Raja A, Raja S, Amin SB, et al. Temporal trends in hypertension related end stage renal disease mortality rates: an analysis of gender, race\/ethnicity, and geographic disparities in the United States. Front Nephrol. 2023;3:1339312.","journal-title":"Front Nephrol"},{"issue":"3","key":"1537_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351.","journal-title":"Stat Med"},{"issue":"22","key":"1537_CR21","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1002\/cncr.35535","volume":"130","author":"AN Martin","year":"2024","unstructured":"Martin AN, Chan NW, Cheung DC, et al. A guide to large data sets for population-based cancer research: strengths, limitations, and pitfalls. Cancer. 2024;130(22):3802\u201314.","journal-title":"Cancer"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01537-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01537-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01537-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:42:03Z","timestamp":1784911323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01537-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1537"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01537-4","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"162"}}